Seragnoli F
Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 70, Grand-Pré, CH-1202, Geneva, Switzerland.
ArticlePsilocybin
Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.
ArticlePsilocybin
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.
ArticlePsilocybin
Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
ArticlePsilocybin
Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.
PreprintPsilocybin
Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland
PreprintPsilocybin
Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement
ArticlePsilocybin
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]
ArticlePsychedelics
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.
ArticlePsilocybin
Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.
ArticlePsilocybin
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.
ArticlePsilocybin
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
ArticlePsychedelics
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
ArticleLSD